These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 31222732)

  • 1. Astrocyte-specific transcriptome analysis using the ALDH1L1 bacTRAP mouse reveals novel biomarkers of astrogliosis in response to neurotoxicity.
    Michalovicz LT; Kelly KA; Vashishtha S; Ben-Hamo R; Efroni S; Miller JV; Locker AR; Sullivan K; Broderick G; Miller DB; O'Callaghan JP
    J Neurochem; 2019 Aug; 150(4):420-440. PubMed ID: 31222732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Connexin 30 deficiency attenuates A2 astrocyte responses and induces severe neurodegeneration in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine hydrochloride Parkinson's disease animal model.
    Fujita A; Yamaguchi H; Yamasaki R; Cui Y; Matsuoka Y; Yamada KI; Kira JI
    J Neuroinflammation; 2018 Aug; 15(1):227. PubMed ID: 30103794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of gp130-related cytokines and activation of JAK2/STAT3 pathway in astrocytes precedes up-regulation of glial fibrillary acidic protein in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of neurodegeneration: key signaling pathway for astrogliosis in vivo?
    Sriram K; Benkovic SA; Hebert MA; Miller DB; O'Callaghan JP
    J Biol Chem; 2004 May; 279(19):19936-47. PubMed ID: 14996842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular comparison of GLT1+ and ALDH1L1+ astrocytes in vivo in astroglial reporter mice.
    Yang Y; Vidensky S; Jin L; Jie C; Lorenzini I; Frankl M; Rothstein JD
    Glia; 2011 Feb; 59(2):200-7. PubMed ID: 21046559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early activation of STAT3 regulates reactive astrogliosis induced by diverse forms of neurotoxicity.
    O'Callaghan JP; Kelly KA; VanGilder RL; Sofroniew MV; Miller DB
    PLoS One; 2014; 9(7):e102003. PubMed ID: 25025494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced astrogliosis does not require activation of ornithine decarboxylase.
    O'Callaghan JP; Seidler FJ
    Neurosci Lett; 1992 Dec; 148(1-2):105-8. PubMed ID: 1300481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced damage of striatal dopaminergic fibers attenuates subsequent astrocyte response to MPTP.
    O'Callaghan JP; Miller DB; Reinhard JF
    Neurosci Lett; 1990 Sep; 117(1-2):228-33. PubMed ID: 1981254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Astrocyte-Derived Estrogen Regulates Reactive Astrogliosis and is Neuroprotective following Ischemic Brain Injury.
    Wang J; Sareddy GR; Lu Y; Pratap UP; Tang F; Greene KM; Meyre PL; Tekmal RR; Vadlamudi RK; Brann DW
    J Neurosci; 2020 Dec; 40(50):9751-9771. PubMed ID: 33158962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of the origins of astrocyte response to injury using the dopaminergic neurotoxicant, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
    O'Callaghan JP; Miller DB; Reinhard JF
    Brain Res; 1990 Jun; 521(1-2):73-80. PubMed ID: 1976416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Astrocyte support is important for the compensatory potential of the nigrostriatal system neurons during early neurodegeneration.
    Kuter K; Olech Ł; Głowacka U; Paleczna M
    J Neurochem; 2019 Jan; 148(1):63-79. PubMed ID: 30295916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. α-synuclein oligomers enhance astrocyte-induced synapse formation through TGF-β1 signaling in a Parkinson's disease model.
    Diniz LP; Matias I; Araujo APB; Garcia MN; Barros-Aragão FGQ; Alves-Leon SV; de Souza JM; Foguel D; Figueiredo CP; Braga C; Romão L; Gomes FCA
    J Neurochem; 2019 Jul; 150(2):138-157. PubMed ID: 31009074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The metabesity factor HMG20A potentiates astrocyte survival and reactive astrogliosis preserving neuronal integrity.
    Lorenzo PI; Martin Vazquez E; López-Noriega L; Fuente-Martín E; Mellado-Gil JM; Franco JM; Cobo-Vuilleumier N; Guerrero Martínez JA; Romero-Zerbo SY; Perez-Cabello JA; Rivero Canalejo S; Campos-Caro A; Lachaud CC; Crespo Barreda A; Aguilar-Diosdado M; García Fuentes E; Martin-Montalvo A; Álvarez Dolado M; Martin F; Rojo-Martinez G; Pozo D; Bérmudez-Silva FJ; Comaills V; Reyes JC; Gauthier BR
    Theranostics; 2021; 11(14):6983-7004. PubMed ID: 34093866
    [No Abstract]   [Full Text] [Related]  

  • 13. Indirubins deplete striatal monoamines in the Intact and MPTP-treated mouse brain and block kainate-induced striatal astrogliosis.
    Magiatis P; Polychronopoulos P; Skaltsounis AL; Lozach O; Meijer L; Miller DB; O'Callaghan JP
    Neurotoxicol Teratol; 2010; 32(2):212-9. PubMed ID: 20034560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fingolimod (FTY720) is not protective in the subacute MPTP mouse model of Parkinson's disease and does not lead to a sustainable increase of brain-derived neurotrophic factor.
    Komnig D; Dagli TC; Habib P; Zeyen T; Schulz JB; Falkenburger BH
    J Neurochem; 2018 Dec; 147(5):678-691. PubMed ID: 30152864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aldh1L1 is expressed by postnatal neural stem cells in vivo.
    Foo LC; Dougherty JD
    Glia; 2013 Sep; 61(9):1533-41. PubMed ID: 23836537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted inhibition of KCa3.1 attenuates TGF-β-induced reactive astrogliosis through the Smad2/3 signaling pathway.
    Yu Z; Yu P; Chen H; Geller HM
    J Neurochem; 2014 Jul; 130(1):41-49. PubMed ID: 24606313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Astrocyte elevated gene-1 regulates astrocyte responses to neural injury: implications for reactive astrogliosis and neurodegeneration.
    Vartak-Sharma N; Ghorpade A
    J Neuroinflammation; 2012 Aug; 9():195. PubMed ID: 22884085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic correlational analysis reveals no association between MPP+ and the severity of striatal dopaminergic damage following MPTP treatment in BXD mouse strains.
    Jones BC; O'Callaghan JP; Lu L; Williams RW; Alam G; Miller DB
    Neurotoxicol Teratol; 2014; 45():91-2. PubMed ID: 25192776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Arundic acid, an astrocyte-modulating agent, protects dopaminergic neurons against MPTP neurotoxicity in mice.
    Kato H; Kurosaki R; Oki C; Araki T
    Brain Res; 2004 Dec; 1030(1):66-73. PubMed ID: 15567338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The neurotoxicant MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) increases glial fibrillary acidic protein and decreases dopamine levels of the mouse striatum: evidence for glial response to injury.
    Reinhard JF; Miller DB; O'Callaghan JP
    Neurosci Lett; 1988 Dec; 95(1-3):246-51. PubMed ID: 3265770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.